mbbirdy
- Goldman Sachs Sanofi began (Nasdak:Cut) In Neutral, saying that although French drugs “appear as a pipeline story”, the company needs to see more data from candidates before they become more positive.
- The Investment Bank has the price of $ 65 (about 13 % up
https://static.seekingalpha.com/cdn/s3/uploads/getty_images/165090199/image_165090199.jpg?io=getty-c-w750
Source link